Le cluster J. B. Fourtillan - J. Girault
000149 (1994) | J. Girault [France] ; J. M. Malgouyat [France] ; G. Lecomte [France] ; D. Longueville [France] ; B. Istin [France] ; J. B. Fourtillan [France] | Quantitative measurement of BN50727 in human plasma and urine by combined liquid chromatography/negative ion chemical ionization mass spectrometry using a particle beam interface |
000145 (1994) | J. Girault [France] ; J. M. Malgouyat [France] ; D. Longueville [France] ; G. Lecomte [France] ; M. Revaud [France] ; J. B. Fourtillan [France] | Quantitative measurement of a new synthetic hetrazepine derivative, BN50730, in human plasma and urine by combined liquid chromatography—negative chemical ionization mass spectrometry using a particle beam interface |
000148 (1994) | J. Girault [France] ; D. Longueville [France] ; M. Malgouyat [France] ; B. Istin [France] ; G. Lecomte [France] ; B. Fourtillan [France] | Simultaneous quantitative measurement of a new platelet activating factor antagonist (BN 50730) and its two main metabolites in human plasma and urine by LC-MS |
000106 (2000) | J. B. Fourtillan [France] ; A. M. Brisson [France] ; P. Gobin [France] ; I. Ingrand [France] ; J. Ph. Decourt [France] ; J. Girault [France] | Bioavailability of melatonin in humans after day‐time administration of D7 melatonin |
000092 (2001) | M. L Ozoux [France] ; J. Girault [France] ; J. M Malgouyat [France] ; O. Pasquier [France] | Determination of sodium cromoglycate in human plasma by liquid chromatography–mass spectrometry in the turbo ion spray mode |
000142 (1995) | J. B. Fourtillan [France] | Propriétés pharmacocinétiques des nouveaux macrolides. A propos de l'azithromycine |
This area was generated with Dilib version V0.6.20. |